CACNB2 Polyclonal Antibody

Background:
This gene encodes a subunit of a voltage-dependent calcium channel protein that is a member of the voltage-gated calcium channel superfamily. The gene product was originally identified as an antigen target in Lambert-Eaton myasthenic syndrome, an autoimmune disorder. Mutations in this gene are associated with Brugada syndrome. Alternatively spliced variants encoding different isoforms have been described.

Research Area: Neuroscience

Synonyms:
AW060387, Ca(V) beta 2, CAB2, CACB2, CACNB2, CACNLB2, Calcium channel voltage dependent subunit beta 2, Calcium channel voltage-dependent subunit beta 2, Calcium channel, voltage dependent, beta 2 subunit, CAVB2, Cavbeta2, Cchb2, FLJ23743, Lambert Eaton Myasthenic syndrome antigen, Lambert Eaton myasthenic syndrome antigen B, Lambert-Eaton myasthenic syndrome antigen B, MGC129334, MGC129335, Myasthenic (Lambert Eaton) syndrome antigen B, Myasthenic syndrome antigen B, MYSB, Voltage dependent L type calcium channel subunit beta 2, Voltage-dependent L-type calcium channel subunit beta-2

Immunogen: Synthetic peptide of human CACNB2

Swissprot: Q08289
Gene Accession: NP_963890

Purification Method: Affinity purification

Buffer: PBS with 0.05% sodium azide and 50% glycerol, PH7.4

Concentration: 0.4 mg/mL
Dilution: IHC 1:50-1:200

Storage:
Store at -20°C. Avoid freeze / thaw cycles.